HEADER TRANSFERASE 23-JUN-05 2BVA TITLE CRYSTAL STRUCTURE OF THE HUMAN P21-ACTIVATED KINASE 4 COMPND MOL_ID: 1; COMPND 2 MOLECULE: P21-ACTIVATED KINASE 4; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: KINASE DOMAIN, RESIDUES 300-591; COMPND 5 EC: 2.7.1.37; COMPND 6 ENGINEERED: YES; COMPND 7 OTHER_DETAILS: PHOSPHORYLATION ON SER 474 A AND SER 474 B SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 8 EXPRESSION_SYSTEM_VARIANT: R (PHAGE RESISTANT); SOURCE 9 EXPRESSION_SYSTEM_VECTOR: PGEX6B; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PGEX6B-C001 KEYWDS PROTEIN KINASE, STE20, PAK4, ATP-BINDING, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR J.E.DEBRECZENI,G.BUNKOCZI,J.ESWARAN,P.FILIPPAKOPOULOS,S.DAS, AUTHOR 2 O.FEDOROV,M.SUNDSTROM,C.ARROWSMITH,A.EDWARDS,F.VON DELFT,S.KNAPP REVDAT 8 13-NOV-24 2BVA 1 REMARK REVDAT 7 13-DEC-23 2BVA 1 REMARK REVDAT 6 22-MAY-19 2BVA 1 REMARK REVDAT 5 08-MAY-19 2BVA 1 REMARK LINK REVDAT 4 24-JAN-18 2BVA 1 AUTHOR REVDAT 3 24-FEB-09 2BVA 1 VERSN REVDAT 2 20-FEB-07 2BVA 1 JRNL REVDAT 1 14-JUL-05 2BVA 0 JRNL AUTH J.ESWARAN,W.H.LEE,J.E.DEBRECZENI,P.FILIPPAKOPOULOS, JRNL AUTH 2 A.TURNBULL,O.FEDOROV,S.W.DEACON,J.R.PETERSON,S.KNAPP JRNL TITL CRYSTAL STRUCTURES OF THE P21-ACTIVATED KINASES PAK4, PAK5, JRNL TITL 2 AND PAK6 REVEAL CATALYTIC DOMAIN PLASTICITY OF ACTIVE GROUP JRNL TITL 3 II PAKS. JRNL REF STRUCTURE V. 15 201 2007 JRNL REFN ISSN 0969-2126 JRNL PMID 17292838 JRNL DOI 10.1016/J.STR.2007.01.001 REMARK 2 REMARK 2 RESOLUTION. 2.30 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : SHELXL-97 REMARK 3 AUTHORS : G.M.SHELDRICK REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.30 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 20.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 3 CROSS-VALIDATION METHOD : FREE R-VALUE REMARK 3 FREE R VALUE TEST SET SELECTION : THIN SHELLS REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (NO CUTOFF). REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : 0.192 REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : 0.188 REMARK 3 FREE R VALUE (NO CUTOFF) : 0.269 REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : 4.500 REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : 1721 REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : 38368 REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL FOR DATA WITH F>4SIG(F). REMARK 3 R VALUE (WORKING + TEST SET, F>4SIG(F)) : 0.185 REMARK 3 R VALUE (WORKING SET, F>4SIG(F)) : 0.181 REMARK 3 FREE R VALUE (F>4SIG(F)) : 0.263 REMARK 3 FREE R VALUE TEST SET SIZE (%, F>4SIG(F)) : 4.500 REMARK 3 FREE R VALUE TEST SET COUNT (F>4SIG(F)) : 1670 REMARK 3 TOTAL NUMBER OF REFLECTIONS (F>4SIG(F)) : 36828 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4251 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 36 REMARK 3 REMARK 3 MODEL REFINEMENT. REMARK 3 OCCUPANCY SUM OF NON-HYDROGEN ATOMS : 12879. REMARK 3 OCCUPANCY SUM OF HYDROGEN ATOMS : 13065. REMARK 3 NUMBER OF DISCRETELY DISORDERED RESIDUES : 0 REMARK 3 NUMBER OF LEAST-SQUARES PARAMETERS : 17176 REMARK 3 NUMBER OF RESTRAINTS : 22479 REMARK 3 REMARK 3 RMS DEVIATIONS FROM RESTRAINT TARGET VALUES. REMARK 3 BOND LENGTHS (A) : 0.007 REMARK 3 ANGLE DISTANCES (A) : 0.023 REMARK 3 SIMILAR DISTANCES (NO TARGET VALUES) (A) : 0.078 REMARK 3 DISTANCES FROM RESTRAINT PLANES (A) : 0.397 REMARK 3 ZERO CHIRAL VOLUMES (A**3) : 0.036 REMARK 3 NON-ZERO CHIRAL VOLUMES (A**3) : 0.049 REMARK 3 ANTI-BUMPING DISTANCE RESTRAINTS (A) : 0.044 REMARK 3 RIGID-BOND ADP COMPONENTS (A**2) : NULL REMARK 3 SIMILAR ADP COMPONENTS (A**2) : NULL REMARK 3 APPROXIMATELY ISOTROPIC ADPS (A**2) : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED: NULL REMARK 3 REMARK 3 STEREOCHEMISTRY TARGET VALUES : ENGH AND HUBER BASED ON HIC-UP REMARK 3 ENTRY REMARK 3 SPECIAL CASE: NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: 1. HYDROGENS WERE ADDED ON RIDING REMARK 3 POSITIONS 2. TWIN REFINEMENT: PERFECT MEROHEDRAL TWIN, APPARENT REMARK 3 SPACEGROUP P3221, REAL SPACEGROUP P32, TWIN LAW: 010 100 00-1, REMARK 3 BASF: 0.5006 3. NCS RESTRAINTS WERE USED REMARK 4 REMARK 4 2BVA COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 23-JUN-05. REMARK 100 THE DEPOSITION ID IS D_1290024619. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 23-APR-05 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SLS REMARK 200 BEAMLINE : X10SA REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.968 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XDS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 38417 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.300 REMARK 200 RESOLUTION RANGE LOW (A) : 40.400 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 3.500 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 200 DATA REDUNDANCY : 2.700 REMARK 200 R MERGE (I) : 0.06000 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 11.8600 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.30 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.40 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 2.70 REMARK 200 R MERGE FOR SHELL (I) : 0.28000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 3.550 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 1U5R REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 59.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.00 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: SITTING DROPS, 1.5 M NACL, 10% REMARK 280 ETHANOL, VAPOR DIFFUSION, SITTING DROP REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 32 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+2/3 REMARK 290 3555 -X+Y,-X,Z+1/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 37.02000 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 18.51000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLU A 329 REMARK 465 GLY A 330 REMARK 465 SER A 331 REMARK 465 THR A 332 REMARK 465 GLY A 333 REMARK 465 LEU A 354 REMARK 465 ARG A 355 REMARK 465 LYS A 356 REMARK 465 GLN A 357 REMARK 465 GLN A 358 REMARK 465 ARG A 359 REMARK 465 ARG A 360 REMARK 465 GLU A 361 REMARK 465 SER A 466 REMARK 465 LYS A 467 REMARK 465 ASN A 588 REMARK 465 ARG A 589 REMARK 465 THR A 590 REMARK 465 ARG A 591 REMARK 465 SER B 300 REMARK 465 SER B 331 REMARK 465 THR B 332 REMARK 465 GLY B 333 REMARK 465 ARG B 355 REMARK 465 LYS B 356 REMARK 465 GLN B 357 REMARK 465 GLN B 358 REMARK 465 ARG B 359 REMARK 465 ARG B 360 REMARK 465 GLU B 361 REMARK 465 SER B 466 REMARK 465 LYS B 467 REMARK 465 ASN B 588 REMARK 465 ARG B 589 REMARK 465 THR B 590 REMARK 465 ARG B 591 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLN A 303 CD OE1 NE2 REMARK 470 LYS A 326 CG CD CE NZ REMARK 470 SER A 342 OG REMARK 470 LYS A 345 CG CD CE NZ REMARK 470 LYS A 351 CG CD CE NZ REMARK 470 MET A 352 CG SD CE REMARK 470 ASP A 353 CG OD1 OD2 REMARK 470 GLN A 374 CG CD OE1 NE2 REMARK 470 GLU A 390 CG CD OE1 OE2 REMARK 470 LYS A 525 CD CE NZ REMARK 470 HIS A 539 CG ND1 CD2 CE1 NE2 REMARK 470 LYS A 568 CE NZ REMARK 470 GLN B 303 CD OE1 NE2 REMARK 470 PHE B 304 CG CD1 CD2 CE1 CE2 CZ REMARK 470 GLN B 309 CG CD OE1 NE2 REMARK 470 LYS B 326 CG CD CE NZ REMARK 470 MET B 352 CG SD CE REMARK 470 ASP B 353 CG OD1 OD2 REMARK 470 GLU B 390 CG CD OE1 OE2 REMARK 470 LYS B 525 CD CE NZ REMARK 470 LYS B 568 CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG A 439 NE - CZ - NH1 ANGL. DEV. = 3.4 DEGREES REMARK 500 ARG A 439 NE - CZ - NH2 ANGL. DEV. = -3.5 DEGREES REMARK 500 ARG B 551 CD - NE - CZ ANGL. DEV. = 15.4 DEGREES REMARK 500 ARG B 551 NE - CZ - NH2 ANGL. DEV. = 3.5 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 HIS A 301 146.32 170.36 REMARK 500 LEU A 308 -68.55 -99.77 REMARK 500 VAL A 311 32.14 -78.42 REMARK 500 ASP A 322 -55.59 -149.88 REMARK 500 VAL A 335 -89.66 40.32 REMARK 500 ALA A 338 -168.03 -118.59 REMARK 500 SER A 343 -48.78 -132.37 REMARK 500 ASP A 372 77.20 -100.11 REMARK 500 TYR A 373 152.50 169.75 REMARK 500 GLN A 374 119.95 -164.10 REMARK 500 GLU A 376 0.63 -64.09 REMARK 500 ILE A 406 -63.12 -98.79 REMARK 500 ASP A 440 43.16 -143.40 REMARK 500 ASP A 458 71.44 56.65 REMARK 500 PHE A 459 35.10 -91.27 REMARK 500 CYS A 462 179.82 -59.51 REMARK 500 LYS A 473 20.52 -153.10 REMARK 500 ASN A 537 -91.73 -89.56 REMARK 500 LEU A 538 -41.68 68.95 REMARK 500 PRO A 543 -17.76 -49.44 REMARK 500 GLN B 309 -39.78 -39.15 REMARK 500 VAL B 311 40.01 -109.92 REMARK 500 ARG B 318 38.73 -141.61 REMARK 500 SER B 319 -15.98 -142.25 REMARK 500 ILE B 325 131.08 -170.99 REMARK 500 GLU B 329 163.21 175.07 REMARK 500 VAL B 335 -87.05 -143.29 REMARK 500 CYS B 336 -162.85 -75.01 REMARK 500 SER B 343 -60.51 -129.08 REMARK 500 LYS B 345 142.90 -34.93 REMARK 500 ALA B 348 99.61 -67.49 REMARK 500 MET B 352 158.74 166.49 REMARK 500 ASP B 372 75.67 -101.13 REMARK 500 TYR B 373 145.22 177.73 REMARK 500 ASP B 389 37.92 -95.22 REMARK 500 ASP B 440 42.11 -161.34 REMARK 500 SER B 457 -158.23 -131.91 REMARK 500 CYS B 462 170.54 -51.39 REMARK 500 LYS B 473 25.59 -149.48 REMARK 500 PRO B 494 -29.98 -35.50 REMARK 500 TYR B 515 34.52 71.48 REMARK 500 ASN B 537 -90.83 -112.36 REMARK 500 LEU B 538 -35.99 75.47 REMARK 500 LEU B 553 55.10 -92.43 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 VAL B 469 PRO B 470 -145.11 REMARK 500 REMARK 500 REMARK: NULL DBREF 2BVA A 300 591 UNP Q8NCH5 Q8NCH5_HUMAN 300 591 DBREF 2BVA B 300 591 UNP Q8NCH5 Q8NCH5_HUMAN 300 591 SEQRES 1 A 292 SER HIS GLU GLN PHE ARG ALA ALA LEU GLN LEU VAL VAL SEQRES 2 A 292 ASP PRO GLY ASP PRO ARG SER TYR LEU ASP ASN PHE ILE SEQRES 3 A 292 LYS ILE GLY GLU GLY SER THR GLY ILE VAL CYS ILE ALA SEQRES 4 A 292 THR VAL ARG SER SER GLY LYS LEU VAL ALA VAL LYS LYS SEQRES 5 A 292 MET ASP LEU ARG LYS GLN GLN ARG ARG GLU LEU LEU PHE SEQRES 6 A 292 ASN GLU VAL VAL ILE MET ARG ASP TYR GLN HIS GLU ASN SEQRES 7 A 292 VAL VAL GLU MET TYR ASN SER TYR LEU VAL GLY ASP GLU SEQRES 8 A 292 LEU TRP VAL VAL MET GLU PHE LEU GLU GLY GLY ALA LEU SEQRES 9 A 292 THR ASP ILE VAL THR HIS THR ARG MET ASN GLU GLU GLN SEQRES 10 A 292 ILE ALA ALA VAL CYS LEU ALA VAL LEU GLN ALA LEU SER SEQRES 11 A 292 VAL LEU HIS ALA GLN GLY VAL ILE HIS ARG ASP ILE LYS SEQRES 12 A 292 SER ASP SER ILE LEU LEU THR HIS ASP GLY ARG VAL LYS SEQRES 13 A 292 LEU SER ASP PHE GLY PHE CYS ALA GLN VAL SER LYS GLU SEQRES 14 A 292 VAL PRO ARG ARG LYS SEP LEU VAL GLY THR PRO TYR TRP SEQRES 15 A 292 MET ALA PRO GLU LEU ILE SER ARG LEU PRO TYR GLY PRO SEQRES 16 A 292 GLU VAL ASP ILE TRP SER LEU GLY ILE MET VAL ILE GLU SEQRES 17 A 292 MET VAL ASP GLY GLU PRO PRO TYR PHE ASN GLU PRO PRO SEQRES 18 A 292 LEU LYS ALA MET LYS MET ILE ARG ASP ASN LEU PRO PRO SEQRES 19 A 292 ARG LEU LYS ASN LEU HIS LYS VAL SER PRO SER LEU LYS SEQRES 20 A 292 GLY PHE LEU ASP ARG LEU LEU VAL ARG ASP PRO ALA GLN SEQRES 21 A 292 ARG ALA THR ALA ALA GLU LEU LEU LYS HIS PRO PHE LEU SEQRES 22 A 292 ALA LYS ALA GLY PRO PRO ALA SER ILE VAL PRO LEU MET SEQRES 23 A 292 ARG GLN ASN ARG THR ARG SEQRES 1 B 292 SER HIS GLU GLN PHE ARG ALA ALA LEU GLN LEU VAL VAL SEQRES 2 B 292 ASP PRO GLY ASP PRO ARG SER TYR LEU ASP ASN PHE ILE SEQRES 3 B 292 LYS ILE GLY GLU GLY SER THR GLY ILE VAL CYS ILE ALA SEQRES 4 B 292 THR VAL ARG SER SER GLY LYS LEU VAL ALA VAL LYS LYS SEQRES 5 B 292 MET ASP LEU ARG LYS GLN GLN ARG ARG GLU LEU LEU PHE SEQRES 6 B 292 ASN GLU VAL VAL ILE MET ARG ASP TYR GLN HIS GLU ASN SEQRES 7 B 292 VAL VAL GLU MET TYR ASN SER TYR LEU VAL GLY ASP GLU SEQRES 8 B 292 LEU TRP VAL VAL MET GLU PHE LEU GLU GLY GLY ALA LEU SEQRES 9 B 292 THR ASP ILE VAL THR HIS THR ARG MET ASN GLU GLU GLN SEQRES 10 B 292 ILE ALA ALA VAL CYS LEU ALA VAL LEU GLN ALA LEU SER SEQRES 11 B 292 VAL LEU HIS ALA GLN GLY VAL ILE HIS ARG ASP ILE LYS SEQRES 12 B 292 SER ASP SER ILE LEU LEU THR HIS ASP GLY ARG VAL LYS SEQRES 13 B 292 LEU SER ASP PHE GLY PHE CYS ALA GLN VAL SER LYS GLU SEQRES 14 B 292 VAL PRO ARG ARG LYS SEP LEU VAL GLY THR PRO TYR TRP SEQRES 15 B 292 MET ALA PRO GLU LEU ILE SER ARG LEU PRO TYR GLY PRO SEQRES 16 B 292 GLU VAL ASP ILE TRP SER LEU GLY ILE MET VAL ILE GLU SEQRES 17 B 292 MET VAL ASP GLY GLU PRO PRO TYR PHE ASN GLU PRO PRO SEQRES 18 B 292 LEU LYS ALA MET LYS MET ILE ARG ASP ASN LEU PRO PRO SEQRES 19 B 292 ARG LEU LYS ASN LEU HIS LYS VAL SER PRO SER LEU LYS SEQRES 20 B 292 GLY PHE LEU ASP ARG LEU LEU VAL ARG ASP PRO ALA GLN SEQRES 21 B 292 ARG ALA THR ALA ALA GLU LEU LEU LYS HIS PRO PHE LEU SEQRES 22 B 292 ALA LYS ALA GLY PRO PRO ALA SER ILE VAL PRO LEU MET SEQRES 23 B 292 ARG GLN ASN ARG THR ARG MODRES 2BVA SEP A 474 SER PHOSPHOSERINE MODRES 2BVA SEP B 474 SER PHOSPHOSERINE HET SEP A 474 10 HET SEP B 474 10 HETNAM SEP PHOSPHOSERINE HETSYN SEP PHOSPHONOSERINE FORMUL 1 SEP 2(C3 H8 N O6 P) FORMUL 3 HOH *36(H2 O) HELIX 1 1 ARG A 305 LEU A 310 1 6 HELIX 2 2 LEU A 363 ASP A 372 1 10 HELIX 3 3 LEU A 403 THR A 408 1 6 HELIX 4 4 ASN A 413 GLN A 434 1 22 HELIX 5 5 LYS A 442 ASP A 444 5 3 HELIX 6 6 THR A 478 MET A 482 5 5 HELIX 7 7 ALA A 483 SER A 488 1 6 HELIX 8 8 PRO A 494 ASP A 510 1 17 HELIX 9 9 PRO A 519 ASP A 529 1 11 HELIX 10 10 SER A 542 LEU A 553 1 12 HELIX 11 11 ASP A 556 ARG A 560 5 5 HELIX 12 12 THR A 562 LEU A 567 1 6 HELIX 13 13 LYS A 568 ALA A 575 5 8 HELIX 14 14 PRO A 577 ARG A 586 1 10 HELIX 15 15 HIS B 301 GLN B 309 1 9 HELIX 16 16 LEU B 362 ARG B 371 1 10 HELIX 17 17 ALA B 402 THR B 410 1 9 HELIX 18 18 ASN B 413 GLN B 434 1 22 HELIX 19 19 LYS B 442 ASP B 444 5 3 HELIX 20 20 THR B 478 MET B 482 5 5 HELIX 21 21 ALA B 483 SER B 488 1 6 HELIX 22 22 GLU B 495 GLY B 511 1 17 HELIX 23 23 PRO B 519 ASP B 529 1 11 HELIX 24 24 SER B 542 ASP B 550 1 9 HELIX 25 25 THR B 562 LYS B 568 1 7 HELIX 26 26 HIS B 569 LYS B 574 5 6 HELIX 27 27 PRO B 577 SER B 580 5 4 HELIX 28 28 ILE B 581 ARG B 586 1 6 SHEET 1 AA 2 MET A 381 LEU A 386 0 SHEET 2 AA 2 LEU A 391 MET A 395 -1 O TRP A 392 N TYR A 385 SHEET 1 AB 2 ILE A 446 LEU A 448 0 SHEET 2 AB 2 VAL A 454 LEU A 456 -1 O LYS A 455 N LEU A 447 SHEET 1 BA 4 ALA B 338 THR B 339 0 SHEET 2 BA 4 LEU B 346 VAL B 349 -1 N VAL B 347 O ALA B 338 SHEET 3 BA 4 LEU B 391 MET B 395 -1 O MET B 395 N ALA B 348 SHEET 4 BA 4 MET B 381 LEU B 386 -1 N TYR B 382 O VAL B 394 SHEET 1 BB 2 VAL B 436 ILE B 437 0 SHEET 2 BB 2 ALA B 463 GLN B 464 -1 O ALA B 463 N ILE B 437 SHEET 1 BC 2 ILE B 446 LEU B 448 0 SHEET 2 BC 2 VAL B 454 LEU B 456 -1 O LYS B 455 N LEU B 447 LINK C LYS A 473 N SEP A 474 1555 1555 1.33 LINK C SEP A 474 N LEU A 475 1555 1555 1.33 LINK C LYS B 473 N SEP B 474 1555 1555 1.34 LINK C SEP B 474 N LEU B 475 1555 1555 1.33 CRYST1 118.110 118.110 55.530 90.00 90.00 120.00 P 32 6 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.008467 0.004888 0.000000 0.00000 SCALE2 0.000000 0.009776 0.000000 0.00000 SCALE3 0.000000 0.000000 0.018008 0.00000 MTRIX1 1 -0.499720 -0.866160 -0.006760 -0.37658 1 MTRIX2 1 -0.866080 0.499770 -0.011460 -0.01682 1 MTRIX3 1 0.013300 0.000130 -0.999910 -18.42605 1